VolitionRX launches Nu.Q cancer-screen test for dogs in US, preps for European launch by Heska
VolitionRx (NYSE-A:VNRX) said it has launched its Nu.Q cancer-screening test for use by veterinarians across the US and anticipates the upcoming launch in...
Steve Eyl Tom Butera Heska Corporation Volition Veterinary Diagnostics Development Nevada Based Volitionrx
Source: proactiveinvestors.com